129 related articles for article (PubMed ID: 7044619)
1. Hyper-responsiveness of aldosterone to metoclopramide in aldosteronism.
Gniadek TC; Grekin RJ; Gross MD; Villareal JZ
Clin Endocrinol (Oxf); 1982 May; 16(5):475-81. PubMed ID: 7044619
[No Abstract] [Full Text] [Related]
2. Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronism.
Mizuno K; Yamazaki M; Ikeda K; Yaginuma K; Hashimoto S; Fukuchi S
Jpn Heart J; 1983 Nov; 24(6):917-24. PubMed ID: 6323781
[TBL] [Abstract][Full Text] [Related]
3. Effect of metoclopramide-induced prolactin on aldosterone secretion in normal subjects.
Ogihara T; Matsumura S; Onishi T; Miyai K; Uozumi T
Life Sci; 1977 Feb; 20(3):523-6. PubMed ID: 839976
[No Abstract] [Full Text] [Related]
4. [The effect of metoclopramide, a dopamine inhibitor, on aldosterone secretion in patients with primary aldosteronism].
Mizuno K; Yaginuma K; Yamazaki M; Fukuchi S
Nihon Naibunpi Gakkai Zasshi; 1982 Aug; 58(8):976-83. PubMed ID: 6292008
[No Abstract] [Full Text] [Related]
5. Effect of metoclopramide on plasma aldosterone in normal subjects, primary aldosteronism and hypopituitarism.
Mantero F; Opocher G; Boscaro M; Valpione E; Armanini D; Fallo F
Horm Metab Res; 1981 Aug; 13(8):464-7. PubMed ID: 7035323
[TBL] [Abstract][Full Text] [Related]
6. Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism.
Witzgall H; Lorenz R; von Werder K; Weber PC
Clin Sci (Lond); 1985 Mar; 68(3):291-9. PubMed ID: 3882312
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic regulation of aldosterone secretion: its pathophysiologic significance in subsets of primary aldosteronism.
Naruse M; Naruse K; Yoshimoto T; Tanaka M; Tanabe A; Imaki T; Shibasaki T; Demura R; Demura H
Hypertens Res; 1995 Jun; 18 Suppl 1():S59-64. PubMed ID: 8529076
[TBL] [Abstract][Full Text] [Related]
8. Dopaminergic modulation of aldosterone secretion: effect of sodium balance and postural changes.
García-Robles R; Ruilope L; Mancheño E; Hurtado A; Alcázar JM; Varela C; de la Calle H; Rodicio JL; Sancho J
Rev Esp Fisiol; 1984 Mar; 40(1):63-8. PubMed ID: 6087430
[TBL] [Abstract][Full Text] [Related]
9. Episodic secretion of aldosterone in primary aldosteronism: relationship to cortisol.
Vetter H; Berger M; Armbruster H; Siegenthaler W; Werning C; Vetter W
Clin Endocrinol (Oxf); 1974 Jan; 3(1):41-8. PubMed ID: 4366076
[No Abstract] [Full Text] [Related]
10. Endogenous dopaminergic inhibition of aldosterone and prolactin secretion is apparently not increased in primary aldosteronism.
Jungmann E; Althoff PH; Rosak C; Schwedes U; Schöffling K
Horm Metab Res; 1986 Feb; 18(2):138-40. PubMed ID: 3699687
[TBL] [Abstract][Full Text] [Related]
11. [Aldosterone response to metoclopramide, a dopaminergic inhibitor, in normal men; evaluation of the mechanisms (author's transl)].
Mizuno K; Yamazaki M; Toki T; Ono Y; Hashimoto S; Yaginuma K; Nagasawa S; Fukuchi S
Nihon Jinzo Gakkai Shi; 1982 Feb; 24(2):175-80. PubMed ID: 7047824
[No Abstract] [Full Text] [Related]
12. Escape from the sodium-retaining effects of mineralocorticoids: is there a role for dopamine?
Coruzzi P
J Clin Endocrinol Metab; 1994 Feb; 78(2):455-8. PubMed ID: 8106635
[TBL] [Abstract][Full Text] [Related]
13. Lack of effect of metoclopramide on plasma aldosterone concentrations in young calves.
Safwate A; Tournaire C; Dalle M; Barlet JP
J Physiol (Paris); 1985; 80(5):336-9. PubMed ID: 3831326
[TBL] [Abstract][Full Text] [Related]
14. Differing effects of metoclopramide and adrenocorticotropin on plasma aldosterone levels in glucocorticoid-suppressible hyperaldosteronism and other forms of hyperaldosteronism.
Ganguly A; Pratt JH; Weinberger MH; Grim CE; Fineberg NS
J Clin Endocrinol Metab; 1983 Aug; 57(2):388-92. PubMed ID: 6306041
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic regulation of 18-hydroxycorticosterone and aldosterone secretion in man.
Sowers JR; Beck FW
Acta Endocrinol (Copenh); 1983 Feb; 102(2):258-64. PubMed ID: 6338674
[TBL] [Abstract][Full Text] [Related]
16. Mineralocorticoid and prolactin response to the dopamine antagonist metoclopramide in patients with primary aldosteronism.
Witzgall H; von Werder K; Weber PC
J Steroid Biochem; 1983 Nov; 19(5):1671-6. PubMed ID: 6645503
[TBL] [Abstract][Full Text] [Related]
17. Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension.
Kem DC; Weinberger MH; Higgins JR; Kramer NJ; Gomez-Sanchez C; Holland OB
J Clin Endocrinol Metab; 1978 Apr; 46(4):552-60. PubMed ID: 225341
[TBL] [Abstract][Full Text] [Related]
18. [Suppression and stimulation of plasma renin concentration in primary hyper-aldosteronism].
Beckerhoff R; Wilkinson R; Luetscher JA; Vetter W; Siegenthaler W
Klin Wochenschr; 1972 Aug; 50(16):783-6. PubMed ID: 4341810
[No Abstract] [Full Text] [Related]
19. [Concentration of adrenocorticotrophic hormone and aldosterone secretion in essential hypertension and hyperaldosteronism].
Shkhvatsabaia IK; Pershakova LP; Ustinova SE; Chikhladze NM; Uchitel' IA
Kardiologiia; 1985 Jan; 25(1):16-22. PubMed ID: 2984449
[TBL] [Abstract][Full Text] [Related]
20. [Plasma aldosterone levels in primary aldosteronism. II. Aldosterone and ACTH].
Fukuchi S; Takenouchi T; Nakajima K; Sasaki C
Nihon Naibunpi Gakkai Zasshi; 1973 Jul; 49(7):981-7. PubMed ID: 4353327
[No Abstract] [Full Text] [Related]
[Next] [New Search]
